Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 4 Increases in (–)isoprenaline-stimulated cAMP-levels (10–12 to 10–5 mol/liter) upon incubation of CHW-beta1 cells with a fixed concentration of rabbit (70 nmol/liter) or human anti-beta1-ECII (2 µmol/liter; patient-subgroups A and B). Filled circles or diamonds correspond to the values obtained for rabbit anti-beta1-C or IgG-preparations from healthy subjects, respectively. Error bars indicate the mean ± SD of three experiments. Significance between control values (filled symbols) and those obtained in the presence of anti-beta1-ECII (open symbols) was analyzed by the Scheffé F test. All the values obtained for patient anti-beta1-ECII (subgroups A/B) differed significantly (p < 0.05) from control values in the presence of low (10–12 to 10–10 mol/liter) or high (10–9 to 10–5 mol/liter) isoprenaline concentrations, except those from patient subgroup B at 10–10 mol/liter isoprenaline (p = 0.15, not significant).





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement